Chika Yoshinaga, M.D. Joins Plexus Ventures as Senior Consultant

Sep 15, 2014

Philadelphia, PA – Plexus Ventures LLC, a leading global pharmaceutical business development consultancy, announced today that Dr. Chika Yoshinaga has joined the firm as Senior Consultant. Dr. Yoshinaga comes to Plexus Ventures with a breadth of experience in the pharmaceutical industry.

Dr. Yoshinaga was born and educated in China, earning her M.D. at Shanghai Medical University. After several years of clinical practice at a major Shanghai hospital, Dr. Yoshinaga left to pursue a Master of Science in Bio-Engineering at Yokohama (Japan) National University. During this time, she worked at a research institute to develop and implement a medical examination data system. From there, Dr. Yoshinaga joined NIF SMBC Ventures Co, Ltd., the second largest venture capital firm in Japan, where she headed the European life sciences area and directed equity investments in a number of firms that achieved successful exits. Dr. Yoshinaga moved to Sofinnova Partners, one of the largest and oldest European venture capital firms, to become Chief Representative of their Shanghai office where she set strategy for investing in China-based firms, including development-stage, biotechnology, pharmaceutical and medical device companies. Dr. Yoshinaga returned to Japan to work for Quintiles in a new ventures capacity, responsible for identifying equity investments and M&A transactions to drive growth of the core business in Japan and China.

Dr. Yoshinaga has acquired a deep knowledge and understanding of the Chinese healthcare market, including the R&D, regulatory and commercial environments. She has developed a broad network of contacts at Chinese, Japanese and European companies to facilitate successful collaborations. Dr. Yoshinaga speaks fluent Chinese, Japanese and English.

About Plexus Ventures

Plexus Ventures has earned the title Business Builders in Healthcare over nearly three decades as a leading corporate and business development consultancy for healthcare industry companies. Plexus assists clients of all sizes and capabilities to achieve their strategic business development objectives. Plexus industry professionals are conveniently located in the United States, Europe and Asia-Pacific markets, enabling Plexus to benefit its clients with both local knowledge and global reach.



Celon Pharma enters agreement with Zydus Lifesciences Ltd.

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful conclusion of a licensing agreement of behalf of our client, Celon Pharma. Mr. Michael O’Sullivan, Plexus Ventures’ Managing Partner, stated: “This transaction is an ideal match which...